Neuroprotection for treatment of glaucoma in adults
John Wiley & Sons, Ltd, February 2013
Sena, Dayse F, Lindsley, Kristina
Glaucoma is a heterogeneous group of conditions involving progressive damage to the optic nerve, deterioration of retinal ganglion cells and ultimately visual field loss. It is a leading cause of blindness worldwide. Open angle glaucoma (OAG), the commonest form of glaucoma, is a chronic condition that may or may not present with increased intraocular pressure (IOP). Neuroprotection for glaucoma refers to any intervention intended to prevent optic nerve damage or cell death.
The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.
|Members of the public||5||100%|
The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||14||13%|
|Student > Ph. D. Student||14||13%|
|Student > Doctoral Student||11||10%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||58||55%|
|Agricultural and Biological Sciences||12||11%|
|Biochemistry, Genetics and Molecular Biology||5||5%|
|Nursing and Health Professions||3||3%|
|Pharmacology, Toxicology and Pharmaceutical Science||3||3%|